Health Care

4449 posts
Knee joint injection with hyaluronic acid for osteoarthritis treatment. Medical procedure using syringe in sterile hospital environment. Professional orthopedic therapy for joint pain relief.

Paradigm Biopharma rolls into CY26 on patient tailwinds after hitting 25% recruitment milestone

Late-stage drug developer Paradigm Biopharmaceuticals is preparing for a huge CY26 after landing a key recruitment…
Memphasys (ASX:MEM) Felix™ System

Memphasys locks down 5-year European IVF supply deal

Memphasys has this week executed a long-term European commercial supply agreement with Centro Fertilita Assistita (CFA)…
The Market Online Video

Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie

From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer…
Lung imaging concept

Biotech lung imaging darling 4DX Medical back at $2.20/sh on Miami U contract

4DX Medical has seen its price jump back to $2.20/sh, as its next-gen lung imaging scan…
Chuffed bloke

Race Oncology’s placement-at-a-premium rewarded as shares jump +8%

Race Oncology has completed its recent A$3.2M placement – something that shareholders on the HotCopper forums…

Effective as an IV drug, a gel, and now an inhaler – Recce’s R327 can’t stop winning

Recce flagship antibacertial and anti-infective drug R327 has in a model that shows the drug could…
In vitro fertilisation

Monash IVF soars to 85cps as company rejects takeover offer despite -33% YTD returns

Monash IVF Group has soared +40% on Monday morning as the company rejected a non-binding takeover…
Prostate cancer examination discussion concept

Orthocell pops on nerve healing successes in prostate surgery patients

Orthocell has seen its share price jump on Thursday as the company unveils its latest early-stage…
Biotech chart concept

AFT Pharmaceuticals jumps +10% on $115M interim FY26 record revenue

AFT Pharmaceuticals has seen its price jump +10% just shy of $3/sh on Thursday morning as…
European Medicine Agency headquarters

Prescient Therapeutics jumps +15% on EU regulator interest in PTX-100

Prescient Therapeutics has jumped +15% after EU drug regulator European Medicines Agency awarded orphan drug designation.